Purpose

This study will determine the effectiveness of administrating a dose of cholecystokinin during a binge eating episode in reducing this eating behavior in people with bulimia nervosa.

Type of Study: Observational Type
Setting of Study: 
Clinical Trials.gov number: NCT00308776
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Eligibility

Ages Eligible for Study: 18 Years - 55 Years
Genders Eligible for Study: Female
This study is recruiting Healthy Volunteers.

Criteria

Inclusion Criteria:
-Meets DSM-IV criteria for BN
-BN duration of more than 1 year
-Self-induces vomiting
-Weighs between 80 and 120% of ideal body weight

Location: 
Clinic: Eating Disorders Clinic
Division: Clinical Psychopharmacology

Study chairs or principal investigators:
B. Timothy Walsh M.D., Principal Investigator

Co-investigators:
Michael Devlin,